|
ZFAND5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.37060000518596E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.54289999945811E-07 |
| Normal-vs-Stage2 |
1.69310000464051E-08 |
| Normal-vs-Stage3 |
1.70949998601344E-09 |
| Normal-vs-Stage4 |
1.22330001683935E-09 |
| Stage1-vs-Stage2 |
5.690500E-02 |
| Stage1-vs-Stage3 |
1.998930E-03 |
| Stage1-vs-Stage4 |
1.780020E-03 |
| Stage2-vs-Stage3 |
7.477000E-01 |
| Stage2-vs-Stage4 |
5.595200E-01 |
| Stage3-vs-Stage4 |
7.247200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.6036000012073E-08 |
| Normal-vs-AfricanAmerican |
1.53169999994596E-06 |
| Normal-vs-Asian |
8.29640000032938E-08 |
| Caucasian-vs-AfricanAmerican |
9.855800E-01 |
| Caucasian-vs-Asian |
7.997600E-01 |
| AfricanAmerican-vs-Asian |
8.715200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.47199999861658E-08 |
| Normal-vs-Female |
2.66409999616357E-08 |
| Male-vs-Female |
9.276800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.9757999998068E-07 |
| Normal-vs-Age(41-60Yrs) |
1.51969999917512E-08 |
| Normal-vs-Age(61-80Yrs) |
4.32139990458325E-10 |
| Normal-vs-Age(81-100Yrs) |
4.901400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.408000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.58290000000272E-05 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.188200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.043600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.147800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.381600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.536600E-03 |
| Classical-VS-Follicular |
1.276150E-02 |
| Classical-VS-Other |
9.809600E-01 |
| Classical-VS-Normal |
3.42700000044438E-07 |
| Tall-VS-Follicular |
3.156200E-01 |
| Tall-VS-Other |
1.102960E-01 |
| Tall-VS-Normal |
1.55299995086011E-09 |
| Follicular-VS-Other |
4.292000E-01 |
| Follicular-VS-Normal |
1.00539999658977E-08 |
| Other-VS-Normal |
4.48390000000742E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.33819996487262E-09 |
| Normal-vs-N1 |
1.7747000002899E-07 |
| N0-vs-N1 |
3.738400E-01 |
|
|
